James E Signorovitch (James Signorovitch)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Multiple Myeloma

Top Venues

Advances in therapy

Future oncology (London, England)

Circulation. Heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy (2024)
Craig M McDonald, James E Signorovitch, Eugenio Mercuri, Erik H Niks, Brenda Wong, Mirko Fillbrunn, Gautam Sajeev, Erica Yim, Ibrahima Dieye, Debra Miller, Susan J Ward, Nathalie Goemans, null null
Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials. PloS one 19 (6) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Craig M McDonald, James E Signorovitch, Eugenio Mercuri, Erik H Niks, Brenda Wong, Mirko Fillbrunn, Gautam Sajeev, Erica Yim, Ibrahima Dieye, Debra Miller, Susan J Ward, Nathalie Goemans, null null
Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials. PloS one 19 (6) (2024)
Francesco Muntoni, James E Signorovitch, Gautam Sajeev, Nicolae Done, Zhiwen Yao, Nathalie Goemans, Craig McDonald, Eugenio Mercuri, Erik H Niks, Brenda L Wong, Krista Vandenborne, Volker Straub, Imelda J M de Groot, Cuixia Tian, Adnan Manzur, Ibrahima Dieye, Henry Lane, Susan J Ward, Laurent Servais, null null, null null, null null, null null, null null
Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study. PloS one 19 (7) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Craig M McDonald, James E Signorovitch, Eugenio Mercuri, Erik H Niks, Brenda Wong, Mirko Fillbrunn, Gautam Sajeev, Erica Yim, Ibrahima Dieye, Debra Miller, Susan J Ward, Nathalie Goemans, null null
Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials. PloS one 19 (6) (2024)
Francesco Muntoni, James E Signorovitch, Gautam Sajeev, Nicolae Done, Zhiwen Yao, Nathalie Goemans, Craig McDonald, Eugenio Mercuri, Erik H Niks, Brenda L Wong, Krista Vandenborne, Volker Straub, Imelda J M de Groot, Cuixia Tian, Adnan Manzur, Ibrahima Dieye, Henry Lane, Susan J Ward, Laurent Servais, null null, null null, null null, null null, null null
Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study. PloS one 19 (7) (2024)
Francesco Muntoni, James E Signorovitch, Gautam Sajeev, Nicolae Done, Zhiwen Yao, Nathalie Goemans, Craig McDonald, Eugenio Mercuri, Erik H Niks, Brenda L Wong, Krista Vandenborne, Volker Straub, Imelda J M de Groot, Cuixia Tian, Adnan Manzur, Ibrahima Dieye, Henry Lane, Susan J Ward, Laurent Servais, null null, null null, null null, null null, null null
Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study. PloS one 19 (7) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Wei Gao, Arash Mostaghimi, Kavita Gandhi, Nicolae Done, Markqayne Ray, James E Signorovitch, Elyse Swallow, Christopher Carley, Travis Wang, Vanja Sikirica
Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States. Journal of medical economics (2023)
Richard T Maziarz, Usama Gergis, Marie Louise Edwards, Yan Song, Qing Liu, Annika Anderson, James E Signorovitch, Rocio Manghani, Ronit Simantov, Heayoung Shin, Smitha Sivaraman
Healthcare costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective. Blood advances (2023)
James E Signorovitch, Andriy Moshyk, Jing Zhao, Trong Kim Le, Leah Burns, Kyna Gooden, Melissa Hamilton
Overall survival in the real-world and clinical trials: a case study validating external controls in advanced melanoma. Future oncology (London, England) 18 (11) (2022)
Matthew John Maurer, Preston Dunnmon, Mariana Fontana, Cristina Candida Quarta, Krishna Prasad, Ronald M Witteles, Claudio Rapezzi, James E Signorovitch, Isabelle Lousada, Giampaolo Merlini
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group. Circulation. Heart failure 15 (6) (2022)